Sector: Medical Instruments Supls
Latest Quote @ Thu Jun 6 05:56:59 (15 min delayed)
Last Day's Data
AtriCure, Inc. engages in the development, manufacture, and sale of surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues. It offers the AtriCure Isolator bipolar ablation system, which consists of an ablation sensing unit, a compact power generator that uses its proprietary software and delivers bipolar radio-frequency energy; multiple configurations of its Isolator bipolar ablation clamps; and its multifunctional bipolar Pen. The company also provides Isolator bipolar ablation clamps designed for ablation during open procedures; Isolator Synergy ablation clamps, which are designed to provide full thickness lesions in thicker and more diseased tissues; and endoscopic Isolator bipolar ablation clamps designed for use in minimally invasive procedures. In addition, it offers multifunctional bipolar Pen for the surgical ablation of cardiac tissue; and for temporary pacing, sensing, stimulating, and recording during the evaluation of cardiac arrhythmias. Further, the company sells Lumitip dissector for the dissection of soft tissues during general, thoracic, and certain other surgical procedures; and distributes cryoablation devices that use extreme cold to ablate tissue. AtriCure sells its medical devices through its direct sales force to hospitals and medical clinics primarily in the United States, as well as through distributors in Asia, Europe, Canada, the Middle East, Central America, and South America. The company was founded in 2000 and is headquartered in West Chester, Ohio.